Who
Kendra Adams
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, C4 Therapeutics.
In numbers
- Trades disclosed
- 34
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 18 Sep 2023
- Last trade
- 18 Sep 2026
- Last filed
- 21 Sep 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Sep 2026filed 21 Sep 2026 | CCCC C4 TherapeuticsBiotechnology | SEC FORM 4 Code M | —6,250 at $0.00 | filing |
| 18 Sep 2026filed 21 Sep 2026 | CCCC C4 TherapeuticsBiotechnology | SEC FORM 4 Code F | $9,4072,775 at $3.39 | filing |
| 18 Sep 2026filed 21 Sep 2026 | CCCC C4 TherapeuticsBiotechnology | SEC FORM 4 Code M | —6,250 at $0.00 | filing |
| 18 Sep 2026filed 21 Sep 2026 | CCCC C4 TherapeuticsBiotechnology | SEC FORM 4 Code F | $9,4072,775 at $3.39 | filing |
| 14 Feb 2026filed 18 Feb 2026 | CCCC C4 TherapeuticsBiotechnology | SEC FORM 4 Code M | —30,950 at $0.00 | filing |
| 14 Feb 2026filed 18 Feb 2026 | CCCC C4 TherapeuticsBiotechnology | SEC FORM 4 Code F | $29K15,381 at $1.89 | filing |
| 14 Feb 2026filed 18 Feb 2026 | CCCC C4 TherapeuticsBiotechnology | SEC FORM 4 Code M | —30,950 at $0.00 | filing |
| 14 Feb 2026filed 18 Feb 2026 | CCCC C4 TherapeuticsBiotechnology | SEC FORM 4 Code F | $29K15,381 at $1.89 | filing |
| 13 Feb 2026filed 18 Feb 2026 | CCCC C4 TherapeuticsBiotechnology | SEC FORM 4 Code A | —240,000 at $0.00 | filing |
| 13 Feb 2026filed 18 Feb 2026 | CCCC C4 TherapeuticsBiotechnology | SEC FORM 4 Code M | —3,750 at $0.00 | filing |
| 13 Feb 2026filed 18 Feb 2026 | CCCC C4 TherapeuticsBiotechnology | SEC FORM 4 Code F | $3,5211,863 at $1.89 | filing |
| 13 Feb 2026filed 18 Feb 2026 | CCCC C4 TherapeuticsBiotechnology | SEC FORM 4 Code A | —240,000 at $0.00 | filing |
| 13 Feb 2026filed 18 Feb 2026 | CCCC C4 TherapeuticsBiotechnology | SEC FORM 4 Code M | —3,750 at $0.00 | filing |
| 13 Feb 2026filed 18 Feb 2026 | CCCC C4 TherapeuticsBiotechnology | SEC FORM 4 Code F | $3,5211,863 at $1.89 | filing |
| 18 Sep 2025filed 19 Sep 2025 | CCCC C4 TherapeuticsBiotechnology | SEC FORM 4 Code M | —6,250 at $0.00 | filing |
| 18 Sep 2025filed 19 Sep 2025 | CCCC C4 TherapeuticsBiotechnology | SEC FORM 4 Code F | $9,2132,775 at $3.32 | filing |
| 14 Feb 2025filed 18 Feb 2025 | CCCC C4 Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —130,600 at $0.00 | filing |
| 14 Feb 2025filed 18 Feb 2025 | CCCC C4 TherapeuticsBiotechnology | SEC FORM 4 Code A | —87,100 at $0.00 | filing |
| 14 Feb 2025filed 18 Feb 2025 | CCCC C4 TherapeuticsBiotechnology | SEC FORM 4 Code F | $14K4,559 at $3.18 | filing |
| 13 Feb 2025filed 18 Feb 2025 | CCCC C4 TherapeuticsBiotechnology | SEC FORM 4 Code F | $5,9621,863 at $3.20 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.